Development and characterization of floating spheroids of atorvastatin calcium loaded NLC for enhancement of oral bioavailability

References

• Almeida-Prieto S, Blanco-Mendez J, Otero-Espinar FJ. 2007. Microscopic image analysis techniques for the morophological charterization of pharmaceutical particles: Influence of the software and the factor algorithms used in the shape factor estimation. Eur J Pham Biopharm. 67:766–776.
   PubMed Web of Science ®Google Scholar
• Bataille B, Ligarski K, Jacob M, Thomas C, Duru C. 1993. Study of the influence of spheronization and drying conditions on the physico-mechanical properties of neutral spheroids containing Avicel PH-101 and lactose. Drug Dev Ind Pharm. 19:653–671.
   Web of Science ®Google Scholar
• Belhadj Z, Zhang S, Zhang W, Junlin W. 2013. Formulation development and bioavailability evaluation of a Self-nanoemulsifying Drug Delivery System (SNEDDS) of Atorvastatin Calcium. Int J Pharmaceutics. 29:2051–5782.
   Google Scholar
• Beloqui A, Solinís MÁ, Gascón AR, del Pozo-Rodríguez A, des Rieux A, Préat V. 2013. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier. J Control Release. 166:115–123.
   PubMed Web of Science ®Google Scholar
• Chen CC, Tsai TH, Huang ZR, Fang JY. 2010. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm. 74:474–482.
   PubMed Web of Science ®Google Scholar
• Ghebre-Sellassie. 1989. Pellets: A general overview. In: Ghebre-Sellassie I, Ed. Pharmaceutical Pelletization technology. New York, USA: Marcel Dekker Inc., 37: pp. 1–13.
   Google Scholar
• Goel A, Aggarwal S. 2012. Special emphasis given on spheronization: a review. IJIPLS. 2:76–87.
   Google Scholar
• Kleinebudde P, Knop K. 2007. Direct pelletization of pharmaceutical pellets in fluid-bed processes. In: Salman AD, Hounslow MJ, Seville JPK, Ed. Handbook of Powder Technology: Granulation, Vol. II. London: Elsevier, pp. 779–811.
   Google Scholar
• Kolovou G, Anagnostopoulou K, Cokkinos D. 2005. Pathophysiology of dyslipidemia in the metabolic syndrome. Postgrad Med J. 81:358–366.
   PubMed Web of Science ®Google Scholar
• Koo OM, Heng PW. 2001. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion- spheronization. Chem Pharm Bull. 49:1383–1387.
   PubMed Web of Science ®Google Scholar
• Manjunath K, Venkateswarlu V. 2005. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. J Control Release. 107:215–228.
   PubMed Web of Science ®Google Scholar
• Masciaa S, Patela MJ, Rougha SL, Martin PJ, Wilson DI. 2006. Liquid phase migration in the extrusion and squeezing of microcrystalline cellulose pastes. Eur J Pharma Sci. 29:22–34.
   PubMed Web of Science ®Google Scholar
• McCrindle BW, Ose L, Marais AD. 2003. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr. 143:74–80.
   PubMed Web of Science ®Google Scholar
• Muchow M, Maincent P, Muller RH, Keck CM. 2013. Testosterone undecanoate–increase of oral bioavailability by nanostructured lipid carriers (NLC). J Pharma Technol Drug Res. doi. https://doi.org/10.7243/2050-120X-2-4.
   Google Scholar
• Nowshad S, Pathan MSI. 2013. Preparation and Evaluation of Gastroretentive Floating Pellets of Metronidazole. Bangladesh Pharma J. 16:107–115.
   Google Scholar
• Podczeck F., Rahman, SR, Newton JM. 1999. Evaluation of a standardised procedure to assess the shape of pellets using image analysis. Int J Pharm. 192:123–138.
   PubMed Web of Science ®Google Scholar
• Reiner Z, Tedeschi-Reiner E. 2006. Th-W47: 2 Atherosclerosis—A paradox of Eastern European countries. Atherosclerosis Supplements. 7:461.
   Web of Science ®Google Scholar
• Sharma K, Kumar K, Mishra N. 2014. Nanoparticulate carrier systemml: a novel treatment approach for hyperlipidemia. Drug Deliv. 1–16. doi: https://doi.org/10.3109/10717544.2014.920937.
   Google Scholar
• Sherrington PJ, Oliver R. 1981. Compaction and other granulation methods. In: Granulation, London: Heyden. 81:141–152.
   Google Scholar
• Shishoo, CJ, Shah SA, Rathod IS, Savale SS, Vora MJ. 2001. Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation. Int J Pharm. 228:53–67.
   PubMed Web of Science ®Google Scholar
• Simons LA. 2002. Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia. Am J Cardiol. 90:737–740.
   PubMed Web of Science ®Google Scholar
• Slack J. 1969. Risks of ischaemic heart-disease in familial hyperlipoproteinaemic states. The Lancet. 294:1380–1382.
   Google Scholar
• Yang SC, Zhu JB. 2002. Preparation and characterization of camptothecin solid lipid nanoparticles. Drug Dev Ind Pharm. 28:265–74.
   PubMed Web of Science ®Google Scholar